The Antibody and BioResource (ABR) Core contributes broadly to the basic and translational mission of the Center by focusing on two tools central to rigorous and reproducible biomedical research: ...

In the rapidly evolving field of antibody drug discovery, the ability to efficiently characterize and screen antibodies and antibody drug conjugates (ADCs) is crucial for developing effective ...

In little more than five years, German biotechnology company YUMAB (a phonetic play on HUMAB (human monoclonal antibody) in which the “Y” symbolizes the antibody structure) has become a global ...

Dr. James Hansen, a Yale Cancer Center researcher, and his team discovered that using an antibody related to lupus they can breach the tumor and trigger an immune response to fight it. He says ...

Passive anti-D immune globulin administered to prevent anti-D antibody formation in RhD-negative women who carry and are exposed to RhD-positive fetal RBCs; once called Rh "sensitization," this is ...